Background: There is evidence that air pollution increases the risk of asthma hospi-
and ozone, and particulate matter which may be further subdivided into fine (aerodynamic diameter < 2.5 lm, PM 2.5 ) and coarse (aerodynamic diameter between 2.5 and 10 lm, PM 10 ).
There is at present limited information available regarding the effects of air pollution exposure on individual patients in a real-life setting. This is primarily due to the difficulty of accurately evaluating personal exposures and correlating these with day-to-day variations in disease control. However, increasing miniaturization of air quality monitors over the past 5 years has now made personal exposure monitoring a realistic prospect. 2 Furthermore, satellite remote sensing with geospatial modelling of ground-level air pollution is emerging as an important source of exposure data in epidemiological and cohort studies. 3 Evidence from epidemiological and experimental studies suggests that air pollution may contribute to exacerbations of asthma through oxidative injury to the airways, increased sensitization to aeroallergens, airway remodelling and airway hyper-responsiveness. 4 We therefore hypothesized that personal air pollution exposure is associated with day-to-day variations in asthma symptoms, lung function and airway inflammation. To test this hypothesis, we undertook a prospective single-centre panel study, making use of portable sensors and satellite-based geospatial modelling.
| ME TH ODS

| Participants
Thirty-two patients with asthma were recruited from general respiratory and specialist clinics at Glenfield Hospital, Leicester. Patients were seen at baseline in the stable state, with no changes having been made to their regular inhaled or oral asthma therapy within the preceding 6 weeks. All participants were never smokers or ex-smokers with less than 10 pack-years' smoking history. Asthma was diagnosed in a secondary or tertiary care setting according to British Thoracic Society guidelines. 5 The study was approved by the National Research and Ethics Committee-East Midlands, Leicester, and all participants gave their written informed consent. Participants were recruited and studied on a rolling basis from May 2016 to April 2017. 
| Exposure measurements
| Statistical analysis
Statistical analysis was performed using SPSS 24 (IBM, Armonk, New York, USA). Relationships between exposure and outcome variables were analysed using linear mixed effects models and cross-correlation, with the two techniques giving complementary information.
Linear mixed effects models were used to assess the relationship between linear trends in the exposure and outcome variables over the study period at a group level, with separate models constructed for each clinical outcome. Clinical outcomes were entered as dependent variables in the model, with exposures specified as fixed
effects. An autoregressive covariance structure was specified to account for the observed autocorrelation in the clinical time series.
For outcomes measured daily (symptom scores, PEF and FeNO), the corresponding exposure variable was the average total oxidant reading on the same day measured using the Cairclip unit. For outcomes measured at study visits, the average total oxidant over the previous 2 weeks was used as the corresponding exposure variable for spirometry and the Asthma Quality of Life Questionnaire, and over the previous week for the Asthma Control Questionnaire.
Cross-correlation was used to assess the relationship between day-to-day variations in exposure and outcome variables in individual participants over a range of lag times (À7 to +7 days). Cross-correlation results were assessed individually, and were combined across the group to give the mean and 95% confidence interval cross-correlation at each lag time. Exploratory subgroup analyses were performed, stratifying the group by sex and smoking history (ex-smokers vs never smokers).
| Statistical power calculation
The primary analysis was estimation of the effect of average total oxidant exposure on peak expiratory flow across the cohort, analysed using a linear mixed effects model. Calculation of statistical power was performed by Dr. Matthew Richardson (University of Leicester) using a simulation approach, based upon an internal pilot comprising the first six participants in the study. A linear mixed effects model was fitted to the pilot data; the dependent variable was morning PEF (PEFam), and the independent variable was the daily average personal total oxidant concentration (AverageOX). A random intercept for each subject was also included in the model.
Estimates for the fixed effect intercept, variance of the random intercept and variance of the error term were obtained from the pilot sample. Values for PEFam were then generated according to the regression equation derived from the pilot data, but allowing the F I G U R E 1 Annual mean NO 2 concentrations in 2016 for the City of Leicester. Raw satellite pixels from the ENSEMBLE model data (0.1 degrees resolution in latitude and longitude) were interpolated on a 1 km grid using spatial information from the DEFRA PCM database. 10 Map data are from Google Maps regression coefficient for AverageOX to vary. The random intercept for each subject was assumed to follow a normal distribution, and a normally distributed error term was included in the regression equation. The P-value for the regression coefficient of AverageOX was obtained using 100 simulations, with sample size fixed at n = 30.
Based on the simulation results, it was estimated that this sample size would be sufficient to detect an effect size of AverageOx (p.p.b.) on PEFam (L/min) of approximately 0.7 units with power = 80% at the 5% significance level.
| RESULTS
Thirty-one participants completed the study, with one participant withdrawing at an early stage due to technical problems with the Cairclip unit. Clinical and demographic characteristics of the participants are shown in Table 1 . Participants were followed up for an average of 78 days, with a total of 2406 person-days of follow-up.
The average missing data rate for daily monitoring were 15.5% for morning readings, 21.7% for evening readings and 20.6% for Cairclip total oxidant data. Missing Cairclip data were usually caused by complete discharge of the internal battery, due to the unit being left off charge overnight. This resulted in loss of the timestamp and necessitated return of the unit to the study centre to be reset. Figure 2 shows an example time series of personal total oxidant exposure in a single participant measured using Cairclip. This shows the typical diurnal pattern of exposure, with peak levels during daylight hours, and considerable day-to-day variability with regard to average daily exposure. Figure 3 shows the average total oxidant levels measured using Cairclip at different times of the day over 1911 person-days of observations. A peak is seen during daytime hours, with additional small peaks corresponding to the morning and evening rush hours on weekdays. Although exposure levels were slightly lower on weekends compared to weekdays, clinical outcomes did not differ significantly across the 7 days of the week, as shown in Table S1 . Table 2 shows the results of linear mixed effects models in which the fixed effects of average daily total oxidant exposure measured using Cairclip on clinical outcomes were estimated over the whole study group. In each case, no clinically important or statistically significant effects were observed. Cross-correlation analysis did not reveal any consistent associations between exposure and outcome variables in the study group as a whole, as shown in Figure 4 and Figures S1-S6. When the group was stratified by sex, we observed a positive correlation on the same day (lag 0) between total oxidant exposure using Cairclip and daytime symptoms in women, but not in men ( Figure 5 ). Stratifying the group by smoking history did not reveal any significant associations.
| DISCUSSION
We report the first panel study of the effects of personal air pollution exposure on adults with asthma in which exposures and outcomes were assessed concurrently over an extended 12-week period. We assessed air pollution exposure using three separate methodologies, namely (i) a small portable sensor carried on the [16] [17] [18] [19] but due to the bulky nature of the monitoring equipment, the follow-up duration has necessarily been limited. We have for the first time demonstrated the feasibility of long-term personal air pollution exposure monitoring.
We did not observe strong associations between exposures and clinical outcomes, although an exploratory subgroup analysis suggested the possibility of increased daytime symptoms in women exposed to air pollution. A number of possible explanations may be suggested to explain our findings. The participants in our study were recruited from Leicester and the surrounding area. To increase the generalizability of our results, we did not restrict participation to individuals residing in heavily polluted districts. Therefore, a number of study participants lived in rural areas and may not have had sufficient air pollution exposure to impact on their asthma control.
Indeed, average peak daily exposure to total oxidant measured using
Cairclip monitors was approximately 10 p.p.b. in our study cohort, which is well within United Kingdom and European air quality limits. 20 Future studies should therefore focus more specifically on high-risk populations, such as those living and working in inner-city areas. Moreover, our data collection and statistical methods relied on detecting associations between exposure and outcome variables produced by day-to-day variability and linear trends arising naturally.
We did not impose an experimental change in exposure, as for instance was performed by McCreanor et al who measured changes in forced expiratory volume in one second caused by walking down a busy London street (Oxford Street) compared to a nearby park (Hyde Park). 21 Therefore, the lack of observed associations could also have been due to low levels of day-to-day variability in exposures and/or clinical outcomes.
With 31 participants, we had sufficient statistical power to detect a 21 L/min change in peak expiratory flow in association with a 30 p.p.b. change in total oxidant exposure. It is possible that a true effect existed but that it was too small to detect with our sample size. Indeed, previous cohort studies have often reported smaller effect sizes than this. 22 However, it has been shown that changes in peak expiratory flow of less than 20 L/min are unlikely to result in perceptibly increased symptoms. 23 Therefore, we considered that our sample size was sufficient to detect clinically important effects on lung function.
We endeavoured to reduce the missing data rate by seeing participants frequently at the study centre (every 2 weeks) and providing them with contact details of investigators who could quickly resolve technical issues with the home monitoring equipment. Nevertheless, approximately 15%-20% of daily exposure or outcome F I G U R E 3 Diurnal variation in total oxidant levels measured using Cairclip. Average total oxidant levels are shown during the 24-h daily cycle over 1911 person-days of observations. Results are presented for all days, weekdays (Monday to Friday), and weekends (Saturday and Sunday) data were missing, and this may have reduced the chance of observing positive associations.
In this study, we particularly investigated the effects or air pollution exposure on day-to-day variations in asthma symptoms, lung function and airway inflammation. It is possible that the major effects of air pollution on asthma relate to other aspects of the condition which our study was not designed to measure, such as exacerbations, hospital admissions and lung function decline. Indeed, a recent meta-analysis of 87 epidemiological studies conducted in multiple cities world-wide concluded that short-term exposure to a number of air pollutants results in significantly increased risks of asthma-related hospital admissions. 24 It has been reported in a recent large population-based cohort study that cumulative air pollution exposure is a significant risk factor for progression from asthma to chronic obstructive pulmonary disease.
25 While significant at a population level, these effects may be too subtle to detect in small panel studies.
Susceptibility to the effects of air pollution varies between individuals and is most likely related to genetic factors. 26 Therefore, it is possible that clinically significant effects of air pollution may be confined to a small but important group of individuals with a combination of biological susceptibility and higher-than-average levels of exposure. Future research should seek to detect individuals at particular risk from air pollution and to develop strategies to mitigate this F I G U R E 4 Group-level cross-correlations between total oxidant levels measured using Cairclip and clinical outcomes. Group-level crosscorrelations are shown between total oxidant levels measured using Cairclip and clinical outcomes. The group mean and 95% confidence interval of the cross-correlation are shown for each lag time (d). A lag of zero refers to effects occurring on the same day; positive lags refer to changes in outcome preceded by changes in exposure; negative lags refer to changes in exposure preceded by changes in outcome. PEF = peak expiratory flow; FeNO = fractional exhaled nitric oxide F I G U R E 5 Cross-correlation between total oxidant levels measured using Cairclip and daytime symptoms stratified by sex. Crosscorrelations are shown between total oxidant levels measured using Cairclip and daytime symptoms, in female and male participants (Panels A and B, respectively). The group mean and 95% confidence interval of the cross-correlation are shown for each lag time (d). A lag of zero refers to effects occurring on the same day; positive lags refer to changes in outcome preceded by changes in exposure; negative lags refer to changes in exposure preceded by changes in outcome risk. Our data suggest that women may be more susceptible to the effects of air pollution than men, an observation which is shared with a number of previous studies, 27 and which requires further investigation.
We chose to use total oxidant levels measured using the Cairclip approach is to collect location and activity data using global positioning system-enabled smartphone applications, and to link these to ambient levels of air pollution measured using static ground-level monitors or satellite imaging. Furthermore, personal exposure to air pollution is dependent not only on ambient levels but also on the activity being undertaken and the rate of ventilation, which can also be estimated using wearable technology.
In conclusion, we were unable to find compelling evidence that air pollution exposure impacts on day-to-day clinical control in an unselected asthma population, but these results should be taken in the context of the relatively small study population and the low levels of exposure experienced. Future studies should focus on selected individuals who are highly exposed to air pollution due to their lifestyle or place of residence. Our results suggest the possibility of increased susceptibility to air pollution in women compared to men, but this observation requires confirmation in further prospective studies. We have for the first time demonstrated the feasibility of long-term personal exposure monitoring. Sensor technology and geospatial data processing is developing rapidly and will in the near future enable us to further understand the relationship between health and the environment in a variety of long-term medical conditions.
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